The global Efavirenz market size was estimated at USD 131 million in 2023 and is projected to reach USD 194.68 million by 2032, exhibiting a CAGR of 4.50% during the forecast period.
North America Efavirenz market size was estimated at USD 36.82 million in 2023, at a CAGR of 3.86% during the forecast period of 2025 through 2032.
Report Overview
Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
This report provides a deep insight into the global Efavirenz market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Efavirenz Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Efavirenz market in any manner.
Global Efavirenz Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Bristol-Myers Squibb
- Teva
- Mylan
- Aurobindo Pharma
- Cipla
- Macleods Pharmaceuticals
- Hetero
Market Segmentation (by Type)
- Two-drug combination
- Three-drug combination
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Efavirenz Market
- Overview of the regional outlook of the Efavirenz Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Efavirenz Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Efavirenz, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Efavirenz
1.2 Key Market Segments
1.2.1 Efavirenz Segment by Type
1.2.2 Efavirenz Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Efavirenz Market Overview
2.1 Global Market Overview
2.1.1 Global Efavirenz Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Efavirenz Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Efavirenz Market Competitive Landscape
3.1 Global Efavirenz Sales by Manufacturers (2019-2025)
3.2 Global Efavirenz Revenue Market Share by Manufacturers (2019-2025)
3.3 Efavirenz Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Efavirenz Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Efavirenz Sales Sites, Area Served, Product Type
3.6 Efavirenz Market Competitive Situation and Trends
3.6.1 Efavirenz Market Concentration Rate
3.6.2 Global 5 and 10 Largest Efavirenz Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Efavirenz Industry Chain Analysis
4.1 Efavirenz Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Efavirenz Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Efavirenz Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Efavirenz Sales Market Share by Type (2019-2025)
6.3 Global Efavirenz Market Size Market Share by Type (2019-2025)
6.4 Global Efavirenz Price by Type (2019-2025)
7 Efavirenz Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Efavirenz Market Sales by Application (2019-2025)
7.3 Global Efavirenz Market Size (M USD) by Application (2019-2025)
7.4 Global Efavirenz Sales Growth Rate by Application (2019-2025)
8 Efavirenz Market Consumption by Region
8.1 Global Efavirenz Sales by Region
8.1.1 Global Efavirenz Sales by Region
8.1.2 Global Efavirenz Sales Market Share by Region
8.2 North America
8.2.1 North America Efavirenz Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Efavirenz Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Efavirenz Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Efavirenz Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Efavirenz Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Efavirenz Market Production by Region
9.1 Global Production of Efavirenz by Region (2019-2025)
9.2 Global Efavirenz Revenue Market Share by Region (2019-2025)
9.3 Global Efavirenz Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Efavirenz Production
9.4.1 North America Efavirenz Production Growth Rate (2019-2025)
9.4.2 North America Efavirenz Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Efavirenz Production
9.5.1 Europe Efavirenz Production Growth Rate (2019-2025)
9.5.2 Europe Efavirenz Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Efavirenz Production (2019-2025)
9.6.1 Japan Efavirenz Production Growth Rate (2019-2025)
9.6.2 Japan Efavirenz Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Efavirenz Production (2019-2025)
9.7.1 China Efavirenz Production Growth Rate (2019-2025)
9.7.2 China Efavirenz Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Efavirenz Basic Information
10.1.2 Bristol-Myers Squibb Efavirenz Product Overview
10.1.3 Bristol-Myers Squibb Efavirenz Product Market Performance
10.1.4 Bristol-Myers Squibb Business Overview
10.1.5 Bristol-Myers Squibb Efavirenz SWOT Analysis
10.1.6 Bristol-Myers Squibb Recent Developments
10.2 Teva
10.2.1 Teva Efavirenz Basic Information
10.2.2 Teva Efavirenz Product Overview
10.2.3 Teva Efavirenz Product Market Performance
10.2.4 Teva Business Overview
10.2.5 Teva Efavirenz SWOT Analysis
10.2.6 Teva Recent Developments
10.3 Mylan
10.3.1 Mylan Efavirenz Basic Information
10.3.2 Mylan Efavirenz Product Overview
10.3.3 Mylan Efavirenz Product Market Performance
10.3.4 Mylan Efavirenz SWOT Analysis
10.3.5 Mylan Business Overview
10.3.6 Mylan Recent Developments
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Efavirenz Basic Information
10.4.2 Aurobindo Pharma Efavirenz Product Overview
10.4.3 Aurobindo Pharma Efavirenz Product Market Performance
10.4.4 Aurobindo Pharma Business Overview
10.4.5 Aurobindo Pharma Recent Developments
10.5 Cipla
10.5.1 Cipla Efavirenz Basic Information
10.5.2 Cipla Efavirenz Product Overview
10.5.3 Cipla Efavirenz Product Market Performance
10.5.4 Cipla Business Overview
10.5.5 Cipla Recent Developments
10.6 Macleods Pharmaceuticals
10.6.1 Macleods Pharmaceuticals Efavirenz Basic Information
10.6.2 Macleods Pharmaceuticals Efavirenz Product Overview
10.6.3 Macleods Pharmaceuticals Efavirenz Product Market Performance
10.6.4 Macleods Pharmaceuticals Business Overview
10.6.5 Macleods Pharmaceuticals Recent Developments
10.7 Hetero
10.7.1 Hetero Efavirenz Basic Information
10.7.2 Hetero Efavirenz Product Overview
10.7.3 Hetero Efavirenz Product Market Performance
10.7.4 Hetero Business Overview
10.7.5 Hetero Recent Developments
11 Efavirenz Market Forecast by Region
11.1 Global Efavirenz Market Size Forecast
11.2 Global Efavirenz Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Efavirenz Market Size Forecast by Country
11.2.3 Asia Pacific Efavirenz Market Size Forecast by Region
11.2.4 South America Efavirenz Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Efavirenz by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Efavirenz Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Efavirenz by Type (2025-2032)
12.1.2 Global Efavirenz Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Efavirenz by Type (2025-2032)
12.2 Global Efavirenz Market Forecast by Application (2025-2032)
12.2.1 Global Efavirenz Sales (K MT) Forecast by Application
12.2.2 Global Efavirenz Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Efavirenz Market Size Comparison by Region (M USD)
Table 5. Global Efavirenz Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Efavirenz Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Efavirenz Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Efavirenz Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Efavirenz as of 2022)
Table 10. Global Market Efavirenz Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Efavirenz Sales Sites and Area Served
Table 12. Manufacturers Efavirenz Product Type
Table 13. Global Efavirenz Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Efavirenz
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Efavirenz Market Challenges
Table 22. Global Efavirenz Sales by Type (K MT)
Table 23. Global Efavirenz Market Size by Type (M USD)
Table 24. Global Efavirenz Sales (K MT) by Type (2019-2025)
Table 25. Global Efavirenz Sales Market Share by Type (2019-2025)
Table 26. Global Efavirenz Market Size (M USD) by Type (2019-2025)
Table 27. Global Efavirenz Market Size Share by Type (2019-2025)
Table 28. Global Efavirenz Price (USD/MT) by Type (2019-2025)
Table 29. Global Efavirenz Sales (K MT) by Application
Table 30. Global Efavirenz Market Size by Application
Table 31. Global Efavirenz Sales by Application (2019-2025) & (K MT)
Table 32. Global Efavirenz Sales Market Share by Application (2019-2025)
Table 33. Global Efavirenz Sales by Application (2019-2025) & (M USD)
Table 34. Global Efavirenz Market Share by Application (2019-2025)
Table 35. Global Efavirenz Sales Growth Rate by Application (2019-2025)
Table 36. Global Efavirenz Sales by Region (2019-2025) & (K MT)
Table 37. Global Efavirenz Sales Market Share by Region (2019-2025)
Table 38. North America Efavirenz Sales by Country (2019-2025) & (K MT)
Table 39. Europe Efavirenz Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Efavirenz Sales by Region (2019-2025) & (K MT)
Table 41. South America Efavirenz Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Efavirenz Sales by Region (2019-2025) & (K MT)
Table 43. Global Efavirenz Production (K MT) by Region (2019-2025)
Table 44. Global Efavirenz Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Efavirenz Revenue Market Share by Region (2019-2025)
Table 46. Global Efavirenz Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Efavirenz Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Efavirenz Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Efavirenz Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Efavirenz Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Bristol-Myers Squibb Efavirenz Basic Information
Table 52. Bristol-Myers Squibb Efavirenz Product Overview
Table 53. Bristol-Myers Squibb Efavirenz Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Bristol-Myers Squibb Business Overview
Table 55. Bristol-Myers Squibb Efavirenz SWOT Analysis
Table 56. Bristol-Myers Squibb Recent Developments
Table 57. Teva Efavirenz Basic Information
Table 58. Teva Efavirenz Product Overview
Table 59. Teva Efavirenz Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Teva Business Overview
Table 61. Teva Efavirenz SWOT Analysis
Table 62. Teva Recent Developments
Table 63. Mylan Efavirenz Basic Information
Table 64. Mylan Efavirenz Product Overview
Table 65. Mylan Efavirenz Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Mylan Efavirenz SWOT Analysis
Table 67. Mylan Business Overview
Table 68. Mylan Recent Developments
Table 69. Aurobindo Pharma Efavirenz Basic Information
Table 70. Aurobindo Pharma Efavirenz Product Overview
Table 71. Aurobindo Pharma Efavirenz Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Aurobindo Pharma Business Overview
Table 73. Aurobindo Pharma Recent Developments
Table 74. Cipla Efavirenz Basic Information
Table 75. Cipla Efavirenz Product Overview
Table 76. Cipla Efavirenz Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Cipla Business Overview
Table 78. Cipla Recent Developments
Table 79. Macleods Pharmaceuticals Efavirenz Basic Information
Table 80. Macleods Pharmaceuticals Efavirenz Product Overview
Table 81. Macleods Pharmaceuticals Efavirenz Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Macleods Pharmaceuticals Business Overview
Table 83. Macleods Pharmaceuticals Recent Developments
Table 84. Hetero Efavirenz Basic Information
Table 85. Hetero Efavirenz Product Overview
Table 86. Hetero Efavirenz Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Hetero Business Overview
Table 88. Hetero Recent Developments
Table 89. Global Efavirenz Sales Forecast by Region (2025-2032) & (K MT)
Table 90. Global Efavirenz Market Size Forecast by Region (2025-2032) & (M USD)
Table 91. North America Efavirenz Sales Forecast by Country (2025-2032) & (K MT)
Table 92. North America Efavirenz Market Size Forecast by Country (2025-2032) & (M USD)
Table 93. Europe Efavirenz Sales Forecast by Country (2025-2032) & (K MT)
Table 94. Europe Efavirenz Market Size Forecast by Country (2025-2032) & (M USD)
Table 95. Asia Pacific Efavirenz Sales Forecast by Region (2025-2032) & (K MT)
Table 96. Asia Pacific Efavirenz Market Size Forecast by Region (2025-2032) & (M USD)
Table 97. South America Efavirenz Sales Forecast by Country (2025-2032) & (K MT)
Table 98. South America Efavirenz Market Size Forecast by Country (2025-2032) & (M USD)
Table 99. Middle East and Africa Efavirenz Consumption Forecast by Country (2025-2032) & (Units)
Table 100. Middle East and Africa Efavirenz Market Size Forecast by Country (2025-2032) & (M USD)
Table 101. Global Efavirenz Sales Forecast by Type (2025-2032) & (K MT)
Table 102. Global Efavirenz Market Size Forecast by Type (2025-2032) & (M USD)
Table 103. Global Efavirenz Price Forecast by Type (2025-2032) & (USD/MT)
Table 104. Global Efavirenz Sales (K MT) Forecast by Application (2025-2032)
Table 105. Global Efavirenz Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Efavirenz
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Efavirenz Market Size (M USD), 2019-2032
Figure 5. Global Efavirenz Market Size (M USD) (2019-2032)
Figure 6. Global Efavirenz Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Efavirenz Market Size by Country (M USD)
Figure 11. Efavirenz Sales Share by Manufacturers in 2023
Figure 12. Global Efavirenz Revenue Share by Manufacturers in 2023
Figure 13. Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Efavirenz Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Efavirenz Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Efavirenz Market Share by Type
Figure 18. Sales Market Share of Efavirenz by Type (2019-2025)
Figure 19. Sales Market Share of Efavirenz by Type in 2023
Figure 20. Market Size Share of Efavirenz by Type (2019-2025)
Figure 21. Market Size Market Share of Efavirenz by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Efavirenz Market Share by Application
Figure 24. Global Efavirenz Sales Market Share by Application (2019-2025)
Figure 25. Global Efavirenz Sales Market Share by Application in 2023
Figure 26. Global Efavirenz Market Share by Application (2019-2025)
Figure 27. Global Efavirenz Market Share by Application in 2023
Figure 28. Global Efavirenz Sales Growth Rate by Application (2019-2025)
Figure 29. Global Efavirenz Sales Market Share by Region (2019-2025)
Figure 30. North America Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Efavirenz Sales Market Share by Country in 2023
Figure 32. U.S. Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Efavirenz Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Efavirenz Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Efavirenz Sales Market Share by Country in 2023
Figure 37. Germany Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Efavirenz Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Efavirenz Sales Market Share by Region in 2023
Figure 44. China Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Efavirenz Sales and Growth Rate (K MT)
Figure 50. South America Efavirenz Sales Market Share by Country in 2023
Figure 51. Brazil Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Efavirenz Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Efavirenz Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Efavirenz Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Efavirenz Production Market Share by Region (2019-2025)
Figure 62. North America Efavirenz Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Efavirenz Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Efavirenz Production (K MT) Growth Rate (2019-2025)
Figure 65. China Efavirenz Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Efavirenz Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Efavirenz Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Efavirenz Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Efavirenz Market Share Forecast by Type (2025-2032)
Figure 70. Global Efavirenz Sales Forecast by Application (2025-2032)
Figure 71. Global Efavirenz Market Share Forecast by Application (2025-2032)
